title: Intraoperative target-controlled infusion anesthesia application using remifentanil hydrochloride with etomidate in patients with severe burn as monitored using Narcotrend.
abstract: OBJECTIVE
  This study aims to evaluate the feasibility of intraoperative composite target-controlled infusion (TCI) anesthesia application using remifentanil hydrochloride with etomidate in patients with severe burns, as monitored by Narcotrend.
  
  
  METHODS
  A total of 40 patients with severe burns with eschar excisions and skin grafts were randomly and equally grouped into the etomidate (E) and the propofol groups (P). Anesthesia was induced and maintained by a remifentanil hydrochloride TCI combined with etomidate or propofol. The depth of anesthesia and other relevant indicators were recorded through intraoperative electroencephalogram monitoring using a Narcotrend monitor.
  
  
  RESULTS
  No statistically significant differences were observed between the drug withdrawal times, eye opening requirements, or orientation recoveries of the two groups (P>0.05). The cortisol and aldosterone levels in group E were significantly lower than those in group P 24h post operation (P<0.05). No significant differences between the number of operations, hospitalization duration, mean arterial pressure, heart rate, and postoperative adverse reaction incidence of the two groups were observed at each time point (P>0.05).
  
  
  CONCLUSIONS
  The application of a composite remifentanil hydrochloride combined with etomidate TCI is feasible for the early eschar excision in patients with severe burns.
authors.affiliation: Department of Anesthesiology, First Affiliated Hospital of General Hospital of PLA, Beijing 100048, China.
authors.forename: Zhenggang
authors.initials: Z
authors.lastname: Guo
authors.affiliation: Department of Anesthesiology, First Affiliated Hospital of General Hospital of PLA, Beijing 100048, China.
authors.forename: Liwei
authors.initials: L
authors.lastname: Pang
authors.affiliation: Department of Anesthesiology, First Affiliated Hospital of General Hospital of PLA, Beijing 100048, China.
authors.forename: Xiaopeng
authors.initials: X
authors.lastname: Jia
authors.affiliation: Department of Anesthesiology, First Affiliated Hospital of General Hospital of PLA, Beijing 100048, China.
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Wang
authors.affiliation: Department of Anesthesiology, First Affiliated Hospital of General Hospital of PLA, Beijing 100048, China.
authors.forename: Xiaojun
authors.initials: X
authors.lastname: Su
authors.affiliation: Department of Anesthesiology, First Affiliated Hospital of General Hospital of PLA, Beijing 100048, China.
authors.forename: Ping
authors.initials: P
authors.lastname: Li
authors.affiliation: Anesthesia and Operation Center, Chinese PLA General Hospital, Beijing 100853, China. Electronic address: weidongmi@yeah.net.
authors.forename: Weidong
authors.initials: W
authors.lastname: Mi
authors.affiliation: Department of Anesthesiology, First Affiliated Hospital of General Hospital of PLA, Beijing 100048, China. Electronic address: zgdoccn@163.com.
authors.forename: Jianhua
authors.initials: J
authors.lastname: Hao
mesh_terms: D000328:Adult; D000762:Anesthesia Recovery Period; D000768:Anesthesia, General / Q000379:methods*; D018686:Anesthetics, Intravenous / Q000627:therapeutic use*; D002056:Burns / Q000601:surgery*; D004569:Electroencephalography / Q000379:methods; D005045:Etomidate / Q000627:therapeutic use*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007430:Intraoperative Care / Q000379:methods; D008297:Male; D008875:Middle Aged; D016343:Monitoring, Intraoperative / Q000379:methods*; D010880:Piperidines / Q000627:therapeutic use*; D015742:Propofol / Q000627:therapeutic use; D000077208:Remifentanil; D016038:Skin Transplantation / Q000379:methods; D055815:Young Adult
chemical_list: D018686:Anesthetics, Intravenous; D010880:Piperidines; D000077208:Remifentanil; D015742:Propofol; D005045:Etomidate
keywords: Etomidate; Narcotrend; Severe burns; Stress response; Target-control infusion